Phosphorus

What is phosphorus and what does it do in the body?

Phosphorus is an essential mineral. According to the NIH Office of Dietary Supplements, it is a component of bone, teeth, DNA, and RNA; it is part of the cell membrane structure as phospholipid and of adenosine triphosphate (ATP), the body’s main energy source. Many proteins and sugars are phosphorylated; phosphorus also plays a role in regulating gene transcription, activating enzymes, maintaining the pH balance of extracellular fluid, and storing intracellular energy. It makes up about 1–1.4% of lean body mass; 85% of this is in bones and teeth and 15% in blood and soft tissues. ^[1]

Vitamin D and parathyroid hormone (PTH) regulate the metabolism of both phosphorus and calcium; together the two form hydroxyapatite, the main structural component of bone and tooth enamel. The combination of high phosphorus and low calcium intake raises serum PTH levels; evidence on whether this rise reduces bone mineral density is mixed. Phosphorus balance is regulated by the kidneys, bones, and intestines. ^[1]

The normal serum or plasma phosphate level in adults is given as 2.5–4.5 mg/dL (0.81–1.45 mmol/L); serum and plasma phosphate do not necessarily reflect total body phosphorus. ^[1]

That a mineral has a function in the body does not mean that taking more than the requirement improves that function. In this guide, “role in the body,” “deficiency,” and “effect of supplements” are treated as separate questions.

How much phosphorus is needed daily?

EFSA concluded that data were insufficient to derive an average requirement and population reference intake for phosphorus; from the finding that the calcium:phosphorus molar ratio in the body is 1.4:1–1.9:1, it calculated an adequate intake (AI) via calcium reference values. Considering that phosphorus intakes observed in Western countries are much higher than the calculated values, the panel chose the lower end of the ratio (1.4:1); the adult AI is 550 mg/day and also applies in pregnancy and lactation. ^[4] The US Food and Nutrition Board (FNB), on which NIH relies, gives an RDA of 700 mg for adults. ^[1]

NIH’s RDA for ages 9–18 is 1,250 mg. ^[1] The EFSA and TÜBER values in the table are taken from the adult rows of the respective documents. ^{[3] [2]} The values are for population-level planning; they are not individual dose recommendations.

Which foods contain phosphorus, and what is the share of additives?

According to NIH, dairy products, meat and poultry, fish, eggs, nuts, legumes, vegetables, and grains contain phosphorus. In the US, about 20% of total phosphorus intake comes from dairy products and 10% from baked goods. Absorption of naturally occurring phosphorus in foods is 40–70%, and absorption from animal sources is higher than from plant sources. In seeds and unleavened bread, phosphorus is in the form of phytic acid, its storage form; because the human gut lacks the enzyme phytase, most of this phosphorus cannot be absorbed. Calcium can bind some of the phosphorus in foods and prevent its absorption. ^[1]

In the NIH table, only yogurt reaches the 20% and above “high source” threshold. The table refers to US servings. ^[1] TÜBER Table 2.2 gives rich sources of phosphorus as “animal foods (milk, eggs, meat), whole grains.” ^[2]

Phosphate additives in processed foods (phosphoric acid, sodium phosphate, sodium polyphosphate) contribute to total intake: NIH estimates that these additives contribute 300–1,000 mg to daily total phosphorus intake, that is, about 10–50% of intake in Western countries; foods containing additives have on average 67 mg more phosphorus per serving than additive-free equivalents, and absorption of phosphorus from additives is about 70%. Some experts argue that surveys such as NHANES underestimate actual intake because they do not account for the share from additives. ^[1] NIH also reports that most people in the US get more phosphorus than recommended: in NHANES 2015–2016, mean daily intake from foods was 1,189 mg in adult women and 1,596 mg in men. ^[1]

Who gets phosphorus deficiency?

NIH states that phosphorus deficiency (hypophosphatemia) is rare and almost never the result of low dietary intake. Hypophosphatemia mostly arises from medical conditions such as hyperparathyroidism, renal tubular defects, and diabetic ketoacidosis; its consequences include loss of appetite, anemia, proximal muscle weakness, bone pain, rickets and osteomalacia, increased risk of infection, paresthesia, ataxia, and confusion. ^[1] TÜBER Table 2.2 lists phosphorus insufficiency as “growth retardation, disorders of tooth, bone, and nerve structure, tetany.” ^[2]

The groups NIH lists as at risk of deficiency are: premature infants (phosphorus deficiency, together with calcium deficiency, is one of the main causes of osteopenia of prematurity; the bone benefit of extra phosphorus and calcium is unclear), people with rare genetic disorders of phosphorus regulation such as X-linked hypophosphatemic rickets (treatment typically consists of vitamin D and phosphorus supplementation until growth is complete), and people with severe protein or calorie malnutrition. In malnutrition, refeeding syndrome (refeeding hypophosphatemia) can develop within 2–5 days of starting nutrition; NIH states that phosphorus and thiamin prophylaxis in at-risk patients can prevent it. ^[1] In these situations, phosphorus is a physician-supervised treatment; it does not generalize to people without a deficiency.

Why does phosphorus matter in kidney disease?

In chronic kidney disease (CKD), phosphate excretion loses effectiveness and serum phosphate rises; phosphorus retention can lead to CKD-related mineral and bone disorder (CKD-MBD). According to NIH, CKD affects 5–10% of the world’s population. ^[1]

Is high serum phosphorus associated with mortality risk?

A 2011 systematic review and meta-analysis examining the association of serum phosphorus, PTH, and calcium levels with death and cardiovascular events in CKD patients covered 47 cohort studies (327,644 patients). For each 1 mg/dL increase in serum phosphorus, mortality risk increased by 18% (RR 1.18; 95% CI 1.12–1.25). The association with death was not significant for PTH and calcium; for cardiovascular death, there is only one adequately adjusted cohort. The authors conclude that there is an association between higher serum phosphorus and death in CKD. ^[6] This is an observational association; it does not show that lowering phosphorus reduces death. NIH also reports that high phosphate levels do not show the same associations in milder CKD. ^[1]

Does dietary phosphorus restriction work?

The Cochrane review examining dietary interventions for mineral and bone disorder in CKD covers 9 studies (634 participants, study durations 4–24 weeks); only one study reported death, and none reported cardiovascular events or fractures. Low phosphorus intake lowered serum phosphorus (2 studies, 359 participants; mean difference −0.18 mmol/L, 95% CI −0.29 to −0.07); in the single study comparing low phosphorus intake with a normal diet, no significant difference in the number of deaths emerged (279 participants; RR 0.18, 95% CI 0.01–3.82). The authors’ conclusion is that there is limited, low-quality evidence that calcium-enriched bread or low phosphorus/protein intake may have a favorable effect on raising serum calcium and lowering serum phosphorus, the calcium × phosphate product, and FGF-23; large, well-designed randomized trials are said to be needed. ^[7]

NIH reports that the KDIGO CKD-MBD guideline recommends restricting dietary phosphorus alone or together with other treatments in patients with stage 3–5 CKD, but notes that clinical trial data showing that treatments lowering serum phosphate improve patients’ own outcomes are lacking and that the recommendation is weak. NIH also reports that phosphorus restriction may reduce protein intake as well, because fish, meat, and legumes, which are rich in phosphorus, are also rich in protein. ^[1]

What is the relationship between phosphorus and cardiovascular health?

Observational studies reported by NIH show an association of high serum phosphate with cardiovascular risk: in 14,675 participants followed for about 20 years, each 1 mg/dL increase in serum phosphate was associated with a 13% increase in the risk of atrial fibrillation; in a meta-analysis pooling four prospective cohorts (13,515 participants), the risk of cardiovascular death was 36% higher in those with the highest phosphate levels. However, in 7,269 postmenopausal women with osteoporosis followed for 4 years, no association was found between high serum phosphate and cardiovascular outcomes. According to NIH, there is no evidence in the literature on whether restricting phosphorus consumption prevents cardiovascular disease in healthy adults. ^[1]

Is too much phosphorus harmful?

According to NIH, high phosphorus intake rarely causes side effects in healthy people. Some studies found an association between intakes of 1,000 mg/day and above and cardiovascular, kidney, and bone problems and risk of death; others found no link; the UL is based on intakes associated with normal serum phosphate levels. NIH gives ULs of 4,000 mg at ages 19–50 and in lactation, 3,500 mg in pregnancy, 4,000 mg at ages 51–70, and 3,000 mg at ages 71 and over; the UL does not apply to people taking phosphorus supplements under medical supervision. Taking very high amounts in a short time (6,600 mg of sodium phosphate in two doses in one day) can cause hyperphosphatemia. ^[1] NIH also notes that high intake can be a marker of an otherwise unhealthy diet. ^[1]

EFSA’s 2025 UL summary reports that data are insufficient to derive a UL for phosphorus (EFSA NDA Panel, 2005). ^[5] TÜBER Annex 1.5.5 lists 4,000 mg for ages 19–50, 3,500 mg in pregnancy, 4,000 mg in lactation, and 3,000 mg over age 70. ^[2] The two documents therefore differ in approach. The UL is an upper limit for habitual daily intake; it is not a single-serving limit.

Phosphate-containing laxatives and antacids

According to NIH, antacids containing aluminum hydroxide bind phosphorus in the gut, and use for three months or longer can lead to hypophosphatemia; antacids with calcium carbonate also reduce absorption of dietary phosphorus. Some laxatives containing sodium phosphate raise serum phosphate; following 13 reports of death associated with a dose higher than the labeled dose, the FDA issued a warning that taking more than the recommended amount of these products can be dangerous, particularly in people with kidney disease, heart disease, or dehydration. ^[1]

Patients who developed acute renal failure after bowel cleansing with an oral sodium phosphate solution before colonoscopy are described in a case series: among 7,349 native kidney biopsies processed at Columbia University in 2000–2004, nephrocalcinosis was found in 31, of whom 21 presented with acute renal failure after using an oral sodium phosphate solution before colonoscopy (mean age 64; 81% female). Over a mean follow-up of 16.7 months, four patients went on to permanent hemodialysis, and the remaining 17 developed chronic renal failure (mean creatinine 2.4 mg/dL). The study is a single-center, uncontrolled series. ^[8]

How are phosphorus supplements regulated in Türkiye?

For every dietary supplement to be placed on the market in Türkiye, Ministry of Agriculture and Forestry approval is mandatory. ^[12] According to Article 5 of Communiqué 2013/49, as amended by 2015/44, vitamins and minerals may be used only if they appear in Annex-1 and in the forms in Annex-2; daily maximum limits are set in accordance with Annex-3 on the basis of the label declaration, and in products containing vitamins and minerals, the amount stated on the label is at least 15% of the nutrient reference value for ages 11 and over. ^[9] Statements claiming to prevent, treat, or cure disease cannot appear on labels, in presentation, or in advertising. ^[10]

The main table of the Ministry’s Restricted Substances List (September 21, 2026) has no separate row with a daily amount limit for phosphorus as a mineral; in the table “Sources of Vitamins and Minerals Used Before December 31, 2025,” “chemical synthesis” is shown as the source for “Phosphorus (mg).” Phospholipids (such as phosphatidylcholine and phosphatidylserine) appear in the list under a separate “Phospholipids” row with their sources, and the numeric amount columns of this row contain dashes. ^[11]

Evidence table: claim, population, and limits

A personal dose or supplement decision for phosphorus is made by evaluating kidney function, medications used (antacids, laxatives), and total intake together; this guide does not recommend personal doses.